OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
Hao Chen, Huabing Tan, Juan Wan, et al.
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108391-108391
Closed Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Steatotic liver disease, MASLD and risk of chronic kidney disease
Josh Bilson, Alessandro Mantovani, Christopher D. Byrne, et al.
Diabetes & Metabolism (2023) Vol. 50, Iss. 1, pp. 101506-101506
Open Access | Times Cited: 35

Exogenous hydrogen sulfide improves non-alcoholic fatty liver disease by inhibiting endoplasmic reticulum stress/NLRP3 inflammasome pathway
Xiaodi Fu, Qi Zhang, Yuhang Chen, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 1

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status
Chenglin Hu, Yuan Chen, Xinpeng Yin, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1

Novel Thiazolones for the Simultaneous Modulation of PPARγ, COX-2 and 15-LOX to Address Metabolic Disease-associated Portal Inflammation
Mai S. El-Shoukrofy, Azza Ismail, Reem H. Elhamammy, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117415-117415
Open Access | Times Cited: 1

The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease
Yu Zhang, Jiahui Yang, Jiali Min, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Novel Therapeutic Approaches to Liver Fibrosis Based on Targeting Oxidative Stress
Ana Blas‐García, Nadezda Apostolova
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1567-1567
Open Access | Times Cited: 18

The global perspective on peroxisome proliferator-activated receptor γ (PPARγ) in ectopic fat deposition: A review
Yanhao Qiu, Mailin Gan, Xingyu Wang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127042-127042
Closed Access | Times Cited: 17

Inhibition of ferroptosis reverses heart failure with preserved ejection fraction in mice
Yixiao Xiong, Xin Liu, Ling Jiang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7

The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus
Monika Bhardwaj, Papiya Mitra Mazumder
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 7

Selenomethionine protects the liver from dietary deoxynivalenol exposure via Nrf2/PPARγ-GPX4-ferroptosis pathway in mice
Shijie Fan, Luxi Lin, Pingyang Li, et al.
Toxicology (2023) Vol. 501, pp. 153689-153689
Closed Access | Times Cited: 16

The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease
Zhenhua Yang, Awang Danzeng, Qiumeng Liu, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 113-126
Open Access | Times Cited: 15

Harnessing peroxisome proliferator-activated receptor γ agonists to induce Heme Oxygenase-1: a promising approach for pulmonary inflammatory disorders
I‐Ta Lee, Chien-Chung Yang, Chuen‐Mao Yang
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Stachyose ameliorates obesity-related metabolic syndrome via improving intestinal barrier function and remodeling gut microbiota
Ningning He, Haoyu Wang, Shengnan Yu, et al.
Journal of Functional Foods (2024) Vol. 115, pp. 106106-106106
Open Access | Times Cited: 5

Supplementation of Micro- and Macronutrients—A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease
Magdalena Tyczyńska, Gabriela Hunek, Martyna Szczasny, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4916-4916
Open Access | Times Cited: 4

TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation
Xiaomian Li, Wenzhi He, Xi Chen, et al.
Oncogene (2024) Vol. 43, Iss. 27, pp. 2063-2077
Closed Access | Times Cited: 4

Investigation of in vitro protective effects of Mucor racemosus-fermented pine pollen on alcoholic fatty liver and its bioactive components
Ziyi Zhang, Yang Chen, Qiquan Qiao, et al.
Food Bioscience (2025), pp. 105840-105840
Closed Access

Arginase 1 promotes hepatic lipogenesis by regulating ERK2/PPARγ signaling in a non-canonical manner
Yujun Shi, Mingyang Shao, Xiaoyue Cao, et al.
Research Square (Research Square) (2025)
Closed Access

DNA methylation-induced suppression of PRDM16 in colorectal cancer metastasis through the PPARγ/EMT pathway
Yu Wang, Shuai Zheng, Huabin Gao, et al.
Cellular Signalling (2025), pp. 111634-111634
Closed Access

Immune-endocrine crossroads: the impact of nuclear receptors in Tuberculosis and Chagas disease
Ana Rosa Pérez, Óscar Bottasso, Natalia Santucci
Frontiers in Endocrinology (2025) Vol. 16
Open Access

Page 1 - Next Page

Scroll to top